The European Commission has presented new draft Guidelines on Pharmacovigilance for Medicinal Products for Human Use in the EU (Volume 9A). These revised Guidelines, if adopted, will be of great importance to how drug safety is conducted in the EU. Stakeholder comments are due by March 17, 2006.